接受新辅助治疗的晚期结直肠癌的生存预测 - - SEER数据库的研究
Zhuo Han1, Haicheng Yang1, Qing Qiao1
1Department of General Surgery, Tangdu Hospital, The Air Force Medical University, Xi'an, 710038, China.
World journal of surgical oncology
|July 2, 2024
概括
这项研究开发了一种名录模型,用于预测接受新辅助治疗的晚期结直肠癌 (CRC) 患者的生存率. 该模型准确地预测了结果,并显示了临床实用性,特别是在年轻患者身上.
科学领域:
- 在瘤学瘤学.
- 癌症预后 癌症预后
- 临床数据建模临床数据建模
背景情况:
- 淋巴结转移的结肠直肠癌 (CRC) 需要有效的预后工具,特别是在新辅助疗法后.
- 预测晚期CRC患者的整体存活率 (OS) 对于治疗规划至关重要.
研究的目的:
- 在接受新辅助治疗的晚期结直肠癌 (CRC) 患者中确定与整体生存 (OS) 相关的因素.
- 构建和验证一个名ogram模型来预测OS在这个患者队列.
主要方法:
- 利用SEER数据库进行培训 (3:2比) 和测试队列,并获得唐都医院的外部验证.
- 采用单变Cox回归,LASSO回归和随机森林生存分析来选预后变量.
- 使用曲线下的面积 (AUC),校准曲线和决策曲线分析评估模型性能.
主要成果:
- 开发了一个纳米图模型,结合了M阶段,年龄,化疗,CEA,围神经入侵,瘤大小,LODDS,肝转移和辐射等因素.
- 该模型在培训,测试和验证组 (AUC从0.733到0.838) 中对1,3年和5年的操作系统表现出良好的预测准确度.
- 校准和决策曲线分析证实了名图的准确性和临床适用性,对早发性CRC (EOCRC) 的预测比晚发性CRC (LOCRC) 更好.
结论:
- 包括LODDS在内的经过验证的诺姆图模型有效地预测了接受新辅助治疗的晚期CRC患者的预后.
- 该模型对预测整体存活率具有显著的准确性和临床实用性.
- 与晚期发作的结直肠癌相比,名图显示了早期发作的结直肠癌的优异预测价值.
相关概念视频
Cancer Survival Analysis
342
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
342
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


